[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Square2 Systems, Inc.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":41},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":25,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":5},"100600969","cogito-a-turnkey-solution-for-rapidly-developing-evaluating-deploying-and-scaling-digital-therapeutics-100600969",false,"NCT07104396","Cogito: A Turnkey Solution for Rapidly Developing, Evaluating, Deploying, and Scaling Digital Therapeutics","Inclusion Criteria:\n\n* At least 18 years\n* PhD and\u002For MD-level (or equivalent) scientists at academic institutions or digital health companies at the level of Post-doctoral Fellow or higher.\n* Training or trained in substance use disorder (SUDs) research.\n* Must state a specific interest in digital therapeutics for SUDs.\n\nExclusion Criteria:\n\n* Those who do not meet inclusion criteria.",true,"ALL","18 Years",{"count":19,"type":20},20,"ESTIMATED","OBSERVATIONAL","This is a research study to evaluate the usability of the Cogito digital therapeutics development platform.\n\nThe Cogito platform is designed to allow researchers who are seeking to embed an evidence-based behavioral therapy into a digital delivery platform to do so via a drag and drop interface with no programming skills necessary. It will provide the components for building a digital therapeutic for any health condition and population.\n\nAnd in this initial study, the research team plans to examine the usability of Cogito in building a digital therapeutic for substance use disorders (SUDs).",[24],"Substance Use Disorders (SUDs)",[26,27,28],"digital therapeutics","substance use disorders","development platform","RECRUITING","2025-08-05",{"date":32,"type":33},"2025-08-11","ACTUAL",{"date":35,"type":33},"2025-07-02",{"date":37,"type":20},"2025-08-31",{"name":39,"class":40},"Square2 Systems, Inc.","INDUSTRY",""]